FDA Inspection 882156 — Daiichi Sankyo Europe GmbH
The FDA completed an inspection of Daiichi Sankyo Europe GmbH on May 15, 2014 in Pfaffenhofen A.D.Ilm. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 15, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pfaffenhofen A.D.Ilm (Germany)